Bruce Walcheck

6.3k total citations
104 papers, 4.9k citations indexed

About

Bruce Walcheck is a scholar working on Immunology, Oncology and Immunology and Allergy. According to data from OpenAlex, Bruce Walcheck has authored 104 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Immunology, 45 papers in Oncology and 40 papers in Immunology and Allergy. Recurrent topics in Bruce Walcheck's work include Cell Adhesion Molecules Research (40 papers), Immune Cell Function and Interaction (32 papers) and CAR-T cell therapy research (27 papers). Bruce Walcheck is often cited by papers focused on Cell Adhesion Molecules Research (40 papers), Immune Cell Function and Interaction (32 papers) and CAR-T cell therapy research (27 papers). Bruce Walcheck collaborates with scholars based in United States, Germany and Norway. Bruce Walcheck's co-authors include Takashi Kishimoto, Mark A. Jutila, Amy Herrera, Jianming Wu, Jeffrey S. Miller, Ying Li, Julius Kahn, Hemant Kumar Mishra, Rodger P. McEver and Kirsty Moore and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Bruce Walcheck

101 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce Walcheck United States	41	2.7k	1.8k	1.5k	1.3k	479	104	4.9k
Paloma Sánchez‐Mateos Spain	50	3.8k 1.4×	1.9k 1.1×	2.3k 1.5×	1.7k 1.3×	522 1.1×	92	7.2k
Mario Mellado Spain	49	4.5k 1.7×	3.6k 2.0×	2.7k 1.8×	900 0.7×	318 0.7×	122	8.3k
Hitoshi Hasegawa Japan	42	2.3k 0.9×	1.0k 0.6×	1.1k 0.8×	690 0.5×	471 1.0×	190	5.1k
José Miguel Rodríguez‐Frade Spain	38	2.6k 1.0×	2.4k 1.4×	1.7k 1.2×	689 0.5×	179 0.4×	89	4.9k
Tatsuo Kinashi Japan	45	4.0k 1.5×	935 0.5×	2.3k 1.6×	2.0k 1.5×	742 1.5×	96	7.0k
Maria Raffaella Zocchi Italy	45	3.8k 1.4×	1.4k 0.8×	1.6k 1.1×	421 0.3×	463 1.0×	152	6.0k
Daniel F. Legler Switzerland	38	4.3k 1.6×	2.8k 1.6×	2.1k 1.5×	680 0.5×	207 0.4×	97	7.2k
Kensuke Miyake Japan	38	2.8k 1.0×	687 0.4×	2.4k 1.6×	2.0k 1.5×	829 1.7×	92	6.3k
Santos Mañes Spain	46	2.5k 0.9×	1.7k 1.0×	3.2k 2.2×	916 0.7×	271 0.6×	88	6.9k
Henri S. Lichenstein United States	40	2.1k 0.8×	998 0.6×	3.3k 2.2×	839 0.6×	346 0.7×	59	6.3k

Countries citing papers authored by Bruce Walcheck

Since Specialization

Citations

This map shows the geographic impact of Bruce Walcheck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Walcheck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Walcheck more than expected).

Fields of papers citing papers by Bruce Walcheck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Walcheck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Walcheck. The network helps show where Bruce Walcheck may publish in the future.

Co-authorship network of co-authors of Bruce Walcheck

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Walcheck. A scholar is included among the top collaborators of Bruce Walcheck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Walcheck. Bruce Walcheck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Sam C., et al.. (2024). Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. Journal for ImmunoTherapy of Cancer. 12(7). e008959–e008959. 4 indexed citations

Walcheck, Bruce, et al.. (2023). Detection of Antibody-Dependent Cell-Mediated Cytotoxicity—Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization. Antibodies. 12(3). 44–44.

Snyder, Kristin M., Zachary Davis, Martin Hosking, et al.. (2023). iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting. Journal for ImmunoTherapy of Cancer. 11(12). e007280–e007280. 13 indexed citations

Waart, Anniek B. van der, Willemijn Hobo, Jianming Wu, et al.. (2023). Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity. Cytotherapy. 26(3). 252–260. 6 indexed citations

Sangala, Jules, Philippa R Kennedy, Emily J. Pomeroy, et al.. (2023). Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production. The Journal of Immunology. 210(8). 1108–1122. 6 indexed citations

Sheikhi, Abdolkarim, Roeland Lameris, Lisa A. King, et al.. (2021). Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor. Cancers. 13(21). 5446–5446. 17 indexed citations

Mishra, Hemant Kumar, et al.. (2020). Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis. International Journal of Molecular Sciences. 21(18). 6688–6688. 16 indexed citations

Goodridge, Jode, Ryan Bjordahl, Sajid Mahmood, et al.. (2020). FT576: Multi-Specific Off-the-Shelf CAR-NK Cell Therapy Engineered for Enhanced Persistence, Avoidance of Self-Fratricide and Optimized Mab Combination Therapy to Prevent Antigenic Escape and Elicit a Deep and Durable Response in Multiple Myeloma. Blood. 136(Supplement 1). 4–5. 34 indexed citations

Lane, John, Nathan Pankratz, Heather H. Nelson, et al.. (2019). Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study. PLoS ONE. 14(6). e0217868–e0217868. 9 indexed citations

10.

Huang, Zhu, Ryan Bjordahl, Svetlana Gaidarova, et al.. (2017). Genetically Engineered Pluripotent Cell-Derived Natural Killer Cell Therapy Provides Enhanced Antibody Dependent Cellular Cytotoxicity Against Hematologic Malignancies and Solid Tumors in Combination with Monoclonal Antibody Therapy. Blood. 130. 4452–4452. 3 indexed citations

11.

Wang, Yue, Amy Herrera, Ying Li, Kiran Belani, & Bruce Walcheck. (2009). Regulation of Mature ADAM17 by Redox Agents for L-Selectin Shedding. The Journal of Immunology. 182(4). 2449–2457. 109 indexed citations

12.

Li, Ying, Amy Herrera, & Bruce Walcheck. (2007). ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding (97.14). The Journal of Immunology. 178(1_Supplement). S191–S191. 2 indexed citations

13.

Khatri, Mahesh, et al.. (2006). In Vivo Activation of Chicken Macrophages by Infectious Bursal Disease Virus. Viral Immunology. 19(2). 305–315. 48 indexed citations

14.

Ni, Zhenya, James J. Campbell, Gloria A. Niehans, & Bruce Walcheck. (2006). The Monoclonal Antibody CHO-131 Identifies a Subset of Cutaneous Lymphocyte-Associated Antigen T Cells Enriched in P-Selectin-Binding Cells. The Journal of Immunology. 177(7). 4742–4748. 8 indexed citations

15.

Walcheck, Bruce, et al.. (2006). Ameliorating Skin-Homing Receptors on Malignant T Cells with a Fluorosugar Analog of N-acetylglucosamine: P-Selectin Ligand Is a More Sensitive Target than E-Selectin Ligand. Journal of Investigative Dermatology. 126(9). 2065–2073. 28 indexed citations

16.

Kulkarni‐Narla, Anjali, Bruce Walcheck, & David R. Brown. (2001). Opioid receptors on bone marrow neutrophils modulate chemotaxis and CD11b/CD18 expression. European Journal of Pharmacology. 414(2-3). 289–294. 17 indexed citations

17.

Kishimoto, Takashi, et al.. (2001). The Cytoplasmic Domain of L-Selectin Participates in Regulating L-Selectin Endoproteolysis. The Journal of Immunology. 167(3). 1617–1623. 49 indexed citations

18.

Walcheck, Bruce, Kirsty Moore, Rodger P. McEver, & Takashi Kishimoto. (1996). Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro.. Journal of Clinical Investigation. 98(5). 1081–1087. 279 indexed citations

19.

Walcheck, Bruce, et al.. (1996). Generation of a new γ δ T cell-specific monoclonal antibody (GD3.5). Biochemical comparisons of GD3.5 antigen with the previously described Workshop Cluster 1 (WC1) family. The Journal of Immunology. 156(10). 3772–3779. 32 indexed citations

20.

Walcheck, Bruce, et al.. (1993). Bovine gamma/delta T cells bind E-selectin via a novel glycoprotein receptor: first characterization of a lymphocyte/E-selectin interaction in an animal model.. The Journal of Experimental Medicine. 178(3). 853–863. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact